Mira Pharmaceuticals MIRA
NASDAQ MIRA
$0.62 -0.01 (-1.59%)
At close: Oct 23, 2026 · 4:00 PM EDT

Mira Pharmaceuticals (MIRA) Price to Sales (2025)

Updated

Analysis

Mira Pharmaceuticals (MIRA) Price to Sales (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Mira Pharmaceuticals 14.69 Mn -5.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 92.20
Sep 30, 2025 124.72
API Access

Mira Pharmaceuticals Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=MIRA&period=max&api_key=YOUR_API_KEY